235 related articles for article (PubMed ID: 36206873)
21. Wnt/beta-catenin signaling: turning the switch.
Cadigan KM
Dev Cell; 2008 Mar; 14(3):322-3. PubMed ID: 18331712
[TBL] [Abstract][Full Text] [Related]
22. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors.
Perissi V; Aggarwal A; Glass CK; Rose DW; Rosenfeld MG
Cell; 2004 Feb; 116(4):511-26. PubMed ID: 14980219
[TBL] [Abstract][Full Text] [Related]
23. SENP2 regulates MMP13 expression in a bladder cancer cell line through SUMOylation of TBL1/TBLR1.
Tan M; Gong H; Wang J; Tao L; Xu D; Bao E; Liu Z; Qiu J
Sci Rep; 2015 Sep; 5():13996. PubMed ID: 26369384
[TBL] [Abstract][Full Text] [Related]
24. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
Ma M; Yu N
Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
[TBL] [Abstract][Full Text] [Related]
25. Correlations between TBL1XR1 and recurrence of colorectal cancer.
Liu H; Xu Y; Zhang Q; Li K; Wang D; Li S; Ning S; Yang H; Shi W; Liu Z; Chen Y
Sci Rep; 2017 Mar; 7():44275. PubMed ID: 28295012
[TBL] [Abstract][Full Text] [Related]
26. Silencing mediator for retinoid and thyroid hormone receptor and nuclear receptor corepressor attenuate transcriptional activation by the beta-catenin-TCF4 complex.
Song LN; Gelmann EP
J Biol Chem; 2008 Sep; 283(38):25988-99. PubMed ID: 18632669
[TBL] [Abstract][Full Text] [Related]
27. A specific mutation in TBL1XR1 causes Pierpont syndrome.
Heinen CA; Jongejan A; Watson PJ; Redeker B; Boelen A; Boudzovitch-Surovtseva O; Forzano F; Hordijk R; Kelley R; Olney AH; Pierpont ME; Schaefer GB; Stewart F; van Trotsenburg AS; Fliers E; Schwabe JW; Hennekam RC
J Med Genet; 2016 May; 53(5):330-7. PubMed ID: 26769062
[TBL] [Abstract][Full Text] [Related]
28. Recruitment of N-CoR/SMRT-TBLR1 corepressor complex by unliganded thyroid hormone receptor for gene repression during frog development.
Tomita A; Buchholz DR; Shi YB
Mol Cell Biol; 2004 Apr; 24(8):3337-46. PubMed ID: 15060155
[TBL] [Abstract][Full Text] [Related]
29. Two decades of a protooncogene TBL1XR1: from a transcription modulator to cancer therapeutic target.
Du R; Li K; Guo K; Chen Z; Zhao X; Han L; Bian H
Front Oncol; 2024; 14():1309687. PubMed ID: 38347836
[TBL] [Abstract][Full Text] [Related]
30. TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.
Venturutti L; Teater M; Zhai A; Chadburn A; Babiker L; Kim D; Béguelin W; Lee TC; Kim Y; Chin CR; Yewdell WT; Raught B; Phillip JM; Jiang Y; Staudt LM; Green MR; Chaudhuri J; Elemento O; Farinha P; Weng AP; Nissen MD; Steidl C; Morin RD; Scott DW; Privé GG; Melnick AM
Cell; 2020 Jul; 182(2):297-316.e27. PubMed ID: 32619424
[TBL] [Abstract][Full Text] [Related]
31. Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activation.
Qu C; He D; Lu X; Dong L; Zhu Y; Zhao Q; Jiang X; Chang P; Jiang X; Wang L; Zhang Y; Bi L; He J; Peng Y; Su J; Zhang H; Huang H; Li Y; Zhou S; Qu Y; Zhao Y; Zhang Z
J Hepatol; 2016 May; 64(5):1076-1089. PubMed ID: 26778753
[TBL] [Abstract][Full Text] [Related]
32. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
[TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of TBL1Y, a Y-linked homologue of TBL1X related with X-linked late-onset sensorineural deafness.
Yan HT; Shinka T; Kinoshita K; Sato Y; Umeno M; Chen G; Tsuji K; Unemi Y; Yang XJ; Iwamoto T; Nakahori Y
J Hum Genet; 2005; 50(4):175-181. PubMed ID: 15834507
[TBL] [Abstract][Full Text] [Related]
34. The Small Molecule BC-2059 Inhibits Wingless/Integrated (Wnt)-Dependent Gene Transcription in Cancer through Disruption of the Transducin
Soldi R; Halder TG; Sampson S; Vankayalapati H; Weston A; Thode T; Bhalla KN; Ng S; Rodriguez Del Villar R; Drenner K; Kaadige MR; Horrigan SK; Batra SK; Salgia R; Sharma S
J Pharmacol Exp Ther; 2021 Aug; 378(2):77-86. PubMed ID: 34006586
[TBL] [Abstract][Full Text] [Related]
35. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
[TBL] [Abstract][Full Text] [Related]
36. TBL1XR1 is involved in c-Met-mediated tumorigenesis of human nonsmall cell lung cancer.
Zhang T; Liu C; Yu Y; Geng J; Meng Q; Xu S; Zhou F; Chen Y; Jin S; Shen J; Pan B; Meng F; Liu F
Cancer Gene Ther; 2020 Apr; 27(3-4):136-146. PubMed ID: 31243347
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
38. Function of multiple Lis-Homology domain/WD-40 repeat-containing proteins in feed-forward transcriptional repression by silencing mediator for retinoic and thyroid receptor/nuclear receptor corepressor complexes.
Choi HK; Choi KC; Kang HB; Kim HC; Lee YH; Haam S; Park HG; Yoon HG
Mol Endocrinol; 2008 May; 22(5):1093-104. PubMed ID: 18202150
[TBL] [Abstract][Full Text] [Related]
39. FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.
Walker MP; Stopford CM; Cederlund M; Fang F; Jahn C; Rabinowitz AD; Goldfarb D; Graham DM; Yan F; Deal AM; Fedoriw Y; Richards KL; Davis IJ; Weidinger G; Damania B; Major MB
Sci Signal; 2015 Feb; 8(362):ra12. PubMed ID: 25650440
[TBL] [Abstract][Full Text] [Related]
40. Transducin (β)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling.
Li X; Liang W; Liu J; Lin C; Wu S; Song L; Yuan Z
Breast Cancer Res; 2014 Oct; 16(5):465. PubMed ID: 25341494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]